120958 20240319081013.0 doi 10.3389/fpsyg.2022.861643 sideral 131273 ART-2022-131273 eng Lear-Claveras, Ana Analysis of Drug and Health Resource Use Before and After COVID-19 Lockdown in a Population Undergoing Treatment for Depression or Anxiety 2022 Access copy available to the general public Unrestricted IntroductionThe arrival of the COVID-19 pandemic modified the functions of Primary Care (PC) teams, which were forced to focus their resources on the diagnosis and treatment of SARS-CoV-2 infected patients. The disrupted healthcare of individuals with pre-existing mental disorders (depression or anxiety), as well as the psychological decompensation resulting from the lockdown caused by the COVID-19 pandemic, may have modified the use of drugs and health resources by these patients. The aim of this study is to determine the changes in these parameters, between the 6 months prior to the lockdown (09/14/2019 to 03/15/2020) and the 6 months following its end (05/03/2020 to 11/04/2020), in a population undergoing active treatment for depression or anxiety, according to the electronic clinical record.Materials and MethodsReal world data observational study of 110,694 individuals aged >16 years suffering from active or undergoing treatment for depression or anxiety according to the electronic medical records of the Aragon Regional Health Service (Spain). Pharmacological variables [daily dose per inhabitant (DHD) dispensed by pharmacies of: anxiolytics, hypnotics/sedatives, and antidepressants] and variables related to the use of healthcare resources (number of primary and specialized healthcare visits) were considered. Student’s T-tests for paired samples were performed to analyze differences between periods (pre–post). The level of significance was established at 5% (p < 0.05).ResultsThe use of anxiolytic drugs increased as compared to its use over the 6 months prior to the lockdown. In contrast, the consumption of antidepressants was found to decrease. The use of health resources continued to be below pre-pandemic levels, 6 months post-lockdown end.ConclusionChanges in the use of health resources could have a negative impact on the parameters of these diseases. The increase in drug use, especially benzodiazepines, may suggest a worsening of the symptoms during the lockdown and in the subsequent months. It is a worrying sign, which points to the growth of this public health problem and the need for its prevention. info:eu-repo/grantAgreement/ES/DGA/B21-20R-GAIAP info:eu-repo/semantics/openAccess by http://creativecommons.org/licenses/by/3.0/es/ 3.8 2022 PSYCHOLOGY, MULTIDISCIPLINARY 34 / 147 = 0.231 2022 Q1 T1 0.891 2022 Psychology (miscellaneous) 2022 Q2 4.5 2022 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Clavería, Ana Couso-Viana, Sabela Nabbe, Patrice Oliván-Blázquez, Bárbara Universidad de Zaragoza (orcid)0000-0001-6565-9699 4009 740 Universidad de Zaragoza Dpto. Psicología y Sociología Área Psicología Social 13 (2022), 861643 [8 pp.] Front. psychol. Frontiers in Psychology 1664-1078 262582 http://zaguan.unizar.es/record/120958/files/texto_completo.pdf Versión publicada 2295594 http://zaguan.unizar.es/record/120958/files/texto_completo.jpg?subformat=icon icon Versión publicada oai:zaguan.unizar.es:120958 articulos driver 2024-03-18-15:22:40 ARTICLE